Non-approved (off-label) treatments used for MS disease modification on: June 19, 2017, 08:51:45 pm #1 Cellcept (mycophonolate mofetil), Cladribine, Cytoxan (cyclophosphamide), Imuran (Azothioprine), Minocycline, Rituxan (rituximab), and statins are drugs that are prescribed off-label for MS.The National MS Society lists them, with brief descriptions, and this list seems important enough to become a "sticky" thread, always near the top of the page:"Non-approved treatments used for MS disease modification". Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
(Abst.) Anti-JC virus antibody index changes in rituximab-treated MS patients Reply #1 on: August 16, 2018, 03:29:52 pm #2 From PubMed (August 16, 2018) this abstract of an article by researchers at Beth Israel Deaconess Medical Center in Boston has the title "Anti-JC virus antibody index changes in rituximab-treated MS patients": Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients - PubMed Rituximab, a monoclonal antibody to CD20, is an effective treatment for relapsing remitting multiple sclerosis (MS) reducing relapse rate by at least 50% over time. Although the mechanism for this ... PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
